Navient Corporation Stock News

Declining expenses support Navient's (NAVI) Q3 earnings. However, a fall in NII and fee income, as well as an increase in provision for loan losses, affect the results.

Navient (NAVI) delivered earnings and revenue surprises of -2.60% and 11.53%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

WILMINGTON, Del., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI), a leader in technology-enabled education finance and business processing solutions, today posted its 2022 third quarter fi

Lower demand for refinance loans due to the federal loan forgiveness policy, and a decline in fee income and NII are likely to have hurt Navient's (NAVI) Q3 earnings.

Mr Cooper (COOP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Navient (NAVI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

March-April, 2022, UBS, Kiplinger, and Barron's analysts and reporters combined to list five-sets of stocks sorted-as: “Inflation Busters for 2022.” Those five-articles revealed 48 equities, with

WILMINGTON, Del., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI), a leader in technology-enabled education finance and business processing solutions, plans to release its 2022 third quarte

WILMINGTON, Del., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI), a leader in technology-enabled education finance and business processing solutions, plans to release its 2022 third quarter

Upgrades For Federal Signal Corp (NYSE:FSS), DA Davidson upgraded the previous rating of Neutral to Buy. In the second quarter, Federal Signal showed an EPS of $0.53, compared to $0.50 from the year-a

Style Box ETF report for RFG

Upgrades For 3M Co (NYSE:MMM), UBS upgraded the previous rating of Sell to Neutral. For the second quarter, 3M had an EPS of $2.48, compared to year-ago quarter EPS of $2.59. The current stock perform

Morgan Stanley raised the price target on Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) from $625 to $851. Morgan Stanley analyst Matthew Harrison also upgraded the stock from Equal-Weight to Overwe

The shares of Navient Corp (NASDAQ:NAVI) are down 2.1% at $14.69 premarket, after Barclays downgraded the stock to "equal weight" from "overweight," with a price-target cut to $13 from $19.

Titan Machinery and WW International are part of Zacks Bull and Bear of the Day article.